Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04886921
Other study ID # KMUH-IRB-970469
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 24, 2009
Est. completion date September 8, 2014

Study information

Verified date February 2021
Source Kaohsiung Medical University Chung-Ho Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The unilateral transverse rectus abdominis musculocutaneous (TRAM) flap is a major operation widely used for breast reconstruction. It is hypothesized that this surgery has the potential risk of weakening the abdominal wall because it disrupts the integrity of the rectus abdominis muscle (RA), therefore, alters the insertion of the oblique muscles and the biomechanical relationship between the RA muscle and adjacent structures. The purposes of this study were to examine the effects of the TRAM flap surgery on muscle size of abdominal muscles, strength and endurance of trunk muscles, strength and endurance of core stability, as well as the effects of therapeutic exercises on it in post-mastectomy women underwent TRAM surgery.


Description:

This first year of the proposed study was aimed to understand the impacts on abdominal muscle functions. We design a case-control, cross-sectional study. There were 46 women who have undergone TRAM flap and 36 age-matched healthy women. We recorded the biomechanic and electromyographic responses during voluntary limb movements and elicited by unexpected support surface translations and tilts in standing. A six-camera Qualisys motion system was used. Ground reaction forces and moments were acquired by one Kisler force plate. Surface electromyography electrodes were used to record the activity of selected trunk and limb muscles. The second year was aimed to evaluate the effects on abdominal muscle functions after 12 weeks abdominal muscle training in the TRAM women. Outcome measures were the clinical tests for trunk muscle strength, endurance and one-leg standing was also used to exam the abdominal muscle function.


Recruitment information / eligibility

Status Completed
Enrollment 82
Est. completion date September 8, 2014
Est. primary completion date September 8, 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: 1. Healthy adults - Their age should be ranged between 30 - 60 years 2. TRAM flap surgery patients - at least 6 months after the MS pedicled TRAM flap surgery Exclusion Criteria: 1. Healthy adults - a history of injury resulting in an inability to perform activities of daily living - scoliosis or spinal surgery - neurological, neuromuscular, rheumatological or systemic diseases 2. TRAM flap surgery patients - tumor distant metastasis - a history of injury resulting in an inability to perform activities of daily living - scoliosis or spinal surgery - neurological, neuromuscular, rheumatological or systemic diseases

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Abdominal muscle training
Participants will receive 12-week, 60 minutes, 36-session abdominal muscle training in the TRAM women. Aimed to evaluate the effects on abdominal muscle functions after 12 weeks abdominal muscle training in the TRAM women. Outcome measures were the clinical tests for trunk muscle strength, endurance and one-leg standing was also used to exam the abdominal muscle function.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Kaohsiung Medical University Chung-Ho Memorial Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in thickness of abdominal wall muscles at 12-week Using the Ultrasound imaging to measure the thickness of all abdominal wall muscles at rest and in an isometric contraction. The assessments will be conducted 1 and 12 weeks following the intervention
Primary Changes in the cross-sectional area of the rectus abdominis muscle (RA) muscle at 12-week Using the Ultrasound imaging to measure the cross-sectional area of the rectus abdominis muscle at rest and in an isometric contraction. The assessments will be conducted 1 and 12 weeks following the intervention
Primary Changes in strength of the trunk muscles at 12-week Using the dynamometer and clinical tests (prone extension, curl-up and rotational curl-up) to measure the trunk strength The assessments will be conducted 1 and 12 weeks following the intervention
Primary Changes in endurance of the trunk muscles at 12-week Using the clinical tests (abdominal muscle test for strength, unsupported double bend leg lifting for static endurance) to measure the endurance of trunk muscles The assessments will be conducted 1 and 12 weeks following the intervention
Primary Changes in balanced functions at 12-week Using the seconds in the following static position to measure the balance: one-leg standing with the other lift-leg 1 inch of ground clearance; single leg standing with the other lift-leg hip flexion 90 degrees and the tibia vertical to the floor. The assessments will be conducted 1 and 12 weeks following the intervention
Primary Changes in muscle activity of selected trunk and limb muscles at 12-week Using A six-camera Qualisys motion system to measure the muscle activity of selected trunk and limb muscles. The assessments will be conducted 1 and 12 weeks following the intervention
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05558917 - Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery N/A
Active, not recruiting NCT03664778 - Abbreviated Breast MRI After Cancer Treatment
Recruiting NCT03144622 - 18F-FSPG PET/CT Imaging in Patients With Cancers
Completed NCT05452499 - Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae N/A
Active, not recruiting NCT04568902 - Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer Phase 1
Completed NCT02860585 - Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation N/A
Completed NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis Phase 2/Phase 3
Recruiting NCT04557449 - Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors Phase 1/Phase 2
Completed NCT03698942 - Delphinus SoftVueâ„¢ ROC Reader Study
Completed NCT00092950 - Exercise in Women at Risk for Breast Cancer Phase 2
Terminated NCT04123704 - Sitravatinib in Metastatic Breast Cancer Phase 2
Not yet recruiting NCT02151071 - The Breast Surgery EnLight and LightPath Imaging System Study Phase 1/Phase 2
Recruiting NCT02934360 - TR(ACE) Assay Clinical Specimen Study N/A
Active, not recruiting NCT02950064 - A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations Phase 1
Completed NCT02931552 - Nuevo Amanecer II: Translating a Stress Management Program for Latinas N/A
Not yet recruiting NCT02876848 - A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study) N/A
Recruiting NCT02547545 - Breast Cancer Chemotherapy Risk Prediction Mathematical Model N/A
Completed NCT02303366 - Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475 Phase 1
Completed NCT02652975 - Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium N/A
Completed NCT02518477 - Preventive Intervention Against Lymphedema After Breast Cancer Surgery N/A